>

WEBINARS

RSS
>

MEETINGS / EVENTS

RSS
>

FDA MEDWATCH ALERTS

RSS

May 20, 2013

All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility: Recall - Lack Of Sterility Assurance

Summary:

All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility

May 14, 2013

Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses

Summary:

Zolpidem Containing Products Drug Safety Communication

May 09, 2013

The Compounding Shop: FDA News Release - Lack of Sterility Assurance of Drug Products

Summary:

The Compounding Shop FDA News Release Lack of Sterility

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-13CE

... Read more »

Single Copies, Member Price: $360

ASA Sends Letter Supporting S.296

Monday, February 14, 2011

 The American Society of Anesthesiologists (ASA) sent a letter to Senator Amy Klobuchar (D-MN) expressing support for S.296, the "Preserving Access to Life-Saving Medications Act."  This legislation is an important first step towards addressing the serious drug shortages facing patients and physicians today.  The ASA has been a leader on addressing drug shortages. In November, ASA co-convened a "Drug Shortages Summit" to identify the core causes of drug shortages. 

In the letter, ASA President Mark A. Warner M.D., says, "The drug shortages we have encountered during this past year have resulted in harm – even death -- to patients. Countless other near tragedies associated with these drug shortages have been averted by the skills that our anesthesiologists bring to bear every day. If enacted, your bill will help reduce the frequency and severity of these shortages, and we are very grateful."

Click here to read the entire letter. 

« Back to Washington Alerts